EQ
Price
$0.48
Change
-$0.01 (-2.04%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
17.48M
35 days until earnings call
MTNB
Price
$0.54
Change
-$0.02 (-3.57%)
Updated
Apr 3, 01:12 PM (EDT)
Capitalization
2.84M
Ad is loading...

EQ vs MTNB

Header iconEQ vs MTNB Comparison
Open Charts EQ vs MTNBBanner chart's image
Equillium
Price$0.48
Change-$0.01 (-2.04%)
Volume$1.78K
Capitalization17.48M
Matinas Biopharma Holdings
Price$0.54
Change-$0.02 (-3.57%)
Volume$100
Capitalization2.84M
EQ vs MTNB Comparison Chart
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. MTNB commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Hold and MTNB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (EQ: $0.49 vs. MTNB: $0.56)
Brand notoriety: EQ and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 13% vs. MTNB: 12%
Market capitalization -- EQ: $17.48M vs. MTNB: $2.84M
EQ [@Biotechnology] is valued at $17.48M. MTNB’s [@Biotechnology] market capitalization is $2.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 1 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • EQ’s FA Score: 1 green, 4 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, MTNB is a better buy in the long-term than EQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 4 TA indicator(s) are bullish while MTNB’s TA Score has 2 bullish TA indicator(s).

  • EQ’s TA Score: 4 bullish, 5 bearish.
  • MTNB’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, EQ is a better buy in the short-term than MTNB.

Price Growth

EQ (@Biotechnology) experienced а -35.22% price change this week, while MTNB (@Biotechnology) price change was -2.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.01%. For the same industry, the average monthly price growth was -10.13%, and the average quarterly price growth was -14.26%.

Reported Earning Dates

EQ is expected to report earnings on May 08, 2025.

MTNB is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-8.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EQ($17.5M) has a higher market cap than MTNB($2.84M). MTNB YTD gains are higher at: 9.510 vs. EQ (-34.376). EQ has higher annual earnings (EBITDA): -4.46M vs. MTNB (-21.05M). EQ has more cash in the bank: 25.9M vs. MTNB (10.8M). EQ has less debt than MTNB: EQ (497K) vs MTNB (3.07M). EQ has higher revenues than MTNB: EQ (45.9M) vs MTNB (0).
EQMTNBEQ / MTNB
Capitalization17.5M2.84M616%
EBITDA-4.46M-21.05M21%
Gain YTD-34.3769.510-361%
P/E RatioN/AN/A-
Revenue45.9M0-
Total Cash25.9M10.8M240%
Total Debt497K3.07M16%
FUNDAMENTALS RATINGS
EQ vs MTNB: Fundamental Ratings
EQ
MTNB
OUTLOOK RATING
1..100
264
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
9465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EQ's Valuation (22) in the Biotechnology industry is in the same range as MTNB (24). This means that EQ’s stock grew similarly to MTNB’s over the last 12 months.

EQ's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MTNB (100). This means that EQ’s stock grew similarly to MTNB’s over the last 12 months.

EQ's SMR Rating (94) in the Biotechnology industry is in the same range as MTNB (98). This means that EQ’s stock grew similarly to MTNB’s over the last 12 months.

MTNB's Price Growth Rating (65) in the Biotechnology industry is in the same range as EQ (94). This means that MTNB’s stock grew similarly to EQ’s over the last 12 months.

MTNB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EQ (100). This means that MTNB’s stock grew similarly to EQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EQMTNB
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.520.08
+5.92%
C4 Therapeutics
MRNA27.720.56
+2.06%
Moderna
WAFD28.750.53
+1.88%
WaFd
NNOX4.910.08
+1.66%
NANO-X IMAGING Ltd
THAR1.290.01
+0.78%
Tharimmune Inc.